Cargando…
Treatment of hormone positive uterine leiomyosarcoma with aromatase inhibitors
BACKGROUND: Aromatase inhibitors (AIs) have not been used consistently as part of the management of hormone receptor positive uterine leiomyosarcomas (ULMS). As a result, the published data regarding the efficacy of AIs in this subtype of ULMS are sparse. METHODS: We performed a retrospective electr...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4094538/ https://www.ncbi.nlm.nih.gov/pubmed/25018868 http://dx.doi.org/10.1186/2045-3329-4-5 |